METHODS OF USING MYT1 INHIBITORS

Disclosed are methods of using inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1), e.g., in the treatment of subjects in need thereof. L'invention concerne des procédés d'utilisation d'inhibiteurs de la kinase inhibitrice de cdc2 spécifique de la tyrosine et d...

Full description

Saved in:
Bibliographic Details
Main Authors YOUNG, Jordan, VALLÉE, Frédéric, VELOSO, Artur, DUROCHER, Daniel, BEAULIEU, Patrick, SICHERI, Frank, PERRYMAN, Alexander, LIU, Bingcan, ZHANG, Theresa, TRUCHON, Jean-François, FOURTOUNIS, Jimmy, SZYCHOWSKI, Janek, DIETRICH, Evelyne, PAPP, Robert
Format Patent
LanguageEnglish
French
Published 25.11.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are methods of using inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1), e.g., in the treatment of subjects in need thereof. L'invention concerne des procédés d'utilisation d'inhibiteurs de la kinase inhibitrice de cdc2 spécifique de la tyrosine et de la thréonine (Myt1), par exemple , dans le traitement de sujets en ayant besoin.
Bibliography:Application Number: WO2021CA50444